What does the published scientific research say about Gluconobacter cerinus?

Three peer-reviewed PubMed articles reference Gluconobacter cerinus in plant-input contexts. Two focus on biocontrol of table grape (Vitis vinifera) diseases: research published in 2021 found that G. cerinus, isolated from table grapes, inhibited mycelial growth of gray rot and summer bunch rot pathogens — Botrytis cinerea, Aspergillus, Penicillium, and Rhizopus — in dual-culture assays. A companion study on the Gluconobacter cerinus VOC mechanism showed that volatile organic compounds produced by a G. cerinus / Hanseniaspora osmophila consortium (PUCV-VBL) achieved 86% inhibition of B. cinerea in vitro and greater than 70% inhibition in vivo across Red Globe, Thompson Seedless, and Crimson Seedless cultivars.

All cited effects are reported in peer-reviewed research, not regulatory approvals or label claims. The scientific literature on Gluconobacter cerinus as an agricultural input is early-stage, concentrated on biocontrol mode-of-action and growth-promotion screening.